C-MER MEDICAL (03309) spent 280,100 Hong Kong dollars on repurchasing 160,000 shares on December 2nd.
Xima Medical (03309) announced that on December 2, 2025, the company spent 280,100 Hong Kong dollars to repurchase 160,000 shares, with a repurchase price per share of 1.75-1.76 Hong Kong dollars.
C-MER MEDICAL (03309) announced on December 2, 2025 that the company will spend HK$280,100 to repurchase 160,000 shares of stock, with a repurchase price per share of HK$1.75-1.76.
Related Articles
MICROTECH MED-B(02235) spent HK$210,100 on December 2nd to repurchase 31,700 shares.
Shanghai Fosun Pharmaceutical (02196): The drug registration application for Sodium Chloride Injection has been accepted by the National Medical Products Administration.
Fujian Acetron New Materials (300706.SZ) plans to raise funds through private placement of not more than 900 million yuan.
MICROTECH MED-B(02235) spent HK$210,100 on December 2nd to repurchase 31,700 shares.
Shanghai Fosun Pharmaceutical (02196): The drug registration application for Sodium Chloride Injection has been accepted by the National Medical Products Administration.
Fujian Acetron New Materials (300706.SZ) plans to raise funds through private placement of not more than 900 million yuan.
